Annals of Thoracic Medicine (Jan 2022)

Lung cancer screening in the gulf: Rationale and recommendations

  • Sami M Bennji,
  • B Jayakrishnan,
  • Adil H Al-Kindi,
  • Issa Al-Jahdhami,
  • Zamzam Al-Hashami

DOI
https://doi.org/10.4103/atm.atm_69_22
Journal volume & issue
Vol. 17, no. 4
pp. 189 – 192

Abstract

Read online

Lung cancer is the leading cause of cancer-related death worldwide among both men and women. Although advances in therapy have been made, the 5-year survival rates for lung cancer remain poor, ranging from 10% to 20%. One of the main reasons is late presentation, as only 25% of patients are amenable to cure at the time of presentation. Therefore, the emphasis on lung cancer screening (LCS) is growing with the current evidence that has shown benefits with low-dose computed tomography scan of the chest in high-risk populations. LCS remains a debated topic in Gulf Cooperation Council (GCC) countries, possibly due to a lack of local experience. In this article, we explore the rationale and give recommendations on the best approach for LCS in GCC.

Keywords